310 related articles for article (PubMed ID: 21106563)
21. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
22. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
[TBL] [Abstract][Full Text] [Related]
23. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.
de Kraker ME; Davey PG; Grundmann H;
PLoS Med; 2011 Oct; 8(10):e1001104. PubMed ID: 22022233
[TBL] [Abstract][Full Text] [Related]
24. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
25. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.
Lautenbach E; Metlay JP; Bilker WB; Edelstein PH; Fishman NO
Clin Infect Dis; 2005 Oct; 41(7):923-9. PubMed ID: 16142655
[TBL] [Abstract][Full Text] [Related]
26. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
28. Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.
Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
J Am Geriatr Soc; 2006 May; 54(5):804-8. PubMed ID: 16696747
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
Lin WP; Huang YS; Wang JT; Chen YC; Chang SC
BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.
Wu UI; Yang CS; Chen WC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):310-6. PubMed ID: 20688291
[TBL] [Abstract][Full Text] [Related]
32. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
[TBL] [Abstract][Full Text] [Related]
33. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Schwaber MJ; Navon-Venezia S; Kaye KS; Ben-Ami R; Schwartz D; Carmeli Y
Antimicrob Agents Chemother; 2006 Apr; 50(4):1257-62. PubMed ID: 16569837
[TBL] [Abstract][Full Text] [Related]
34. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
36. Mortality associated with bloodstream infection after coronary artery bypass surgery.
Olsen MA; Krauss M; Agniel D; Schootman M; Gentry CN; Yan Y; Damiano RJ; Fraser VJ
Clin Infect Dis; 2008 May; 46(10):1537-46. PubMed ID: 18419488
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by
Zhen X; Stålsby Lundborg C; Sun X; Hu X; Dong H
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322649
[TBL] [Abstract][Full Text] [Related]
38. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
[TBL] [Abstract][Full Text] [Related]
39. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
[TBL] [Abstract][Full Text] [Related]
40. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
